Braveheart Bio, Inc. (BRVE)

CIK 2131524 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Braveheart Bio, Inc..

Recent SEC filings

FiledFormAccession number
Nov 5, 2026SCHEDULE 13G0000315066-26-002715
Sep 10, 2026SCHEDULE 13D/A0000947871-26-000860
Sep 8, 20268-K0001628280-26-060904
Sep 8, 202610-Q0001628280-26-060905
Aug 18, 2026SCHEDULE 13D0000947871-26-000814
Aug 14, 202630002003663-26-000005
Aug 14, 2026SCHEDULE 13D0001889476-26-000004
Aug 14, 2026SCHEDULE 13G0001231919-26-000910
Aug 11, 202640000947871-26-000782
Aug 11, 202640001231919-26-000859
Aug 11, 202640000947871-26-000783
Aug 10, 202640001104659-26-093140
Aug 7, 20268-K0001628280-26-054842
Aug 7, 202640001470831-26-000798
Aug 7, 202640001470831-26-000801
Aug 7, 202640001470831-26-000796
Aug 7, 202640001470831-26-000797
Aug 7, 202640001470831-26-000804
Aug 7, 202640001470831-26-000802
Aug 7, 202640001470831-26-000803
Aug 7, 202640001470831-26-000799
Aug 7, 202640001470831-26-000800
Aug 7, 202640001193125-26-340528
Aug 6, 2026S-80001628280-26-054371
Aug 6, 2026CERT0001354457-26-000761